A randomised, double-blind placebo controlled study of subcutaneous ketamine in the management of cancer pain
收藏DataCite Commons2024-08-15 更新2024-07-13 收录
下载链接：
https://www.uts.edu.au/research/impacct/impacct-trials-coordination-centre/clinical-trials/clinical-trial-datasets/ketamine-complex-cancer-pain
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes: - data for 185 participants with pain caused by cancer (93 allocated to Ketamine, 92 allocated to placebo). Treatment period over 5 days, with follow-up for 4 weeks post treatment. Data available for demographic data, primary outcome as Brief Pain Inventory score, quality of life (as EORTC QLQ -C30 and FACIT-PAL), performance status (as AKPS), opioid use, Global Impression of Change, adverse events (as NCI CTCAE V3.0), carer QOL (as Caregiver QOLC), Medicare Australia data, and survival.
提供机构：
Cancer Symptom Trials (CST)
创建时间：
2023-06-13
